Inspiratory Strength and Respiratory Complications After SCI Injury

NCT02891096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2025-02-24

Study results available
· View outcomes & findings →

Summary

The investigators conducting this study to investigate the relation between the respiratory muscle strength and respiratory complications. To understand more about respiratory complications the influence of different factors (such as in- and expiratory muscle strength, lung function parameters, physical activity, smoking, medications,…) on respiratory complications (such as pneumonia) will be investigated.

Conditions

Interventions

PROCEDURE

inspiratory muscle strength

Measurements: * in- and expiratory muscle strength (5min) * lung function (FVC, FEV1, PEF, PCF) (10 min) Questionnaires: * ISCoS core data-set * ISCoS pulmonary function data sets * ISCoS quality of life questionnaire * questionnaire on individual respiratory muscle training, regular physical exercise and therapies * individual medication/vaccination and other medical complications will be assessed from patient's medical records All measurements will be performed at each of the 4 measurement time-points (up to 4 times during inpatient rehabilitation) and last about 40 min per patient and measurement time-point in total (time with patient).

Sponsors & Collaborators

  • Balgrist University Hospital

    collaborator OTHER
  • Rehab Basel

    collaborator OTHER
  • Clinique Romande de Readaptation

    collaborator NETWORK
  • Rehabilitation Clinic Tobelbad, Austria

    collaborator UNKNOWN
  • Rehabilitation Center Haering, Austria

    collaborator UNKNOWN
  • Austin Hospital, Melbourne Australia

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • Heliomare Rehabilitation, Wijk aan Zee, The Netherlands

    collaborator UNKNOWN
  • BG Unfallklinik Murnau

    collaborator OTHER
  • Swiss Paraplegic Research, Nottwil

    lead NETWORK

Principal Investigators

  • Gabi Mueller, PhD · Swiss Paraplegic Centre Nottwil, Clinical Trial Unit

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02891096 on ClinicalTrials.gov